首页> 美国卫生研究院文献>other >Freeze-Drying of Plant Tissue Containing HBV Surface Antigen for the Oral Vaccine against Hepatitis B
【2h】

Freeze-Drying of Plant Tissue Containing HBV Surface Antigen for the Oral Vaccine against Hepatitis B

机译:含乙肝表面抗原的植物组织的冷冻干燥用于口服乙肝疫苗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to develop a freeze-drying protocol facilitating successful processing of plant material containing the small surface antigen of hepatitis B virus (S-HBsAg) while preserving its VLP structure and immunogenicity. Freeze-drying of the antigen in lettuce leaf tissue, without any isolation or purification step, was investigated. Each process step was consecutively evaluated and the best parameters were applied. Several drying profiles and excipients were tested. The profile of 20°C for 20 h for primary and 22°C for 2 h for secondary drying as well as sucrose expressed efficient stabilisation of S-HBsAg during freeze-drying. Freezing rate and postprocess residual moisture were also analysed as important factors affecting S-HBsAg preservation. The process was reproducible and provided a product with VLP content up to 200 µg/g DW. Assays for VLPs and total antigen together with animal immunisation trials confirmed preservation of antigenicity and immunogenicity of S-HBsAg in freeze-dried powder. Long-term stability tests revealed that the stored freeze-dried product was stable at 4°C for one year, but degraded at elevated temperatures. As a result, a basis for an efficient freeze-drying process has been established and a suitable semiproduct for oral plant-derived vaccine against HBV was obtained.
机译:这项研究的目的是开发一种冻干方案,以促进成功加工含有乙型肝炎病毒小表面抗原(S-HBsAg)的植物材料,同时保留其VLP结构和免疫原性。研究了莴苣叶组织中抗原的冷冻干燥,无需任何分离或纯化步骤。连续评估每个过程步骤,并应用最佳参数。测试了几种干燥曲线和赋形剂。一次干燥的20°C持续20 h,二次干燥的22°C持续2 h的曲线以及蔗糖表明S-HBsAg在冷冻干燥过程中有效稳定。冷冻速度和加工后残留水分也被分析为影响S-HBsAg保存的重要因素。该方法具有可重复性,可提供VLP含量高达200µg / g DW的产品。 VLP和总抗原的测定以及动物免疫试验证实,冻干粉末中S-HBsAg的抗原性和免疫原性得以保留。长期稳定性测试表明,所储存的冷冻干燥产品在4°C下稳定一年,但在高温下会降解。结果,已经建立了有效的冷冻干燥过程的基础,并且获得了适合口服的源自植物的抗HBV疫苗的合适的半成品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号